Anti-HPV16 L1/Major capsid protein L1 Antibody (SAA2553) from ProteoGenix; catalogue ARO-A22999; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for your biotech research needs.
This highly specific antibody targets the L1 protein of the human papillomavirus type 16 (HPV16), a known cause of cervical cancer. By binding to the L1 protein, it effectively blocks the virus from entering host cells, making it an essential tool for studying HPV16 and its role in cancer development.
With its high affinity and specificity, this antibody is ideal for use in various applications, including Western blotting, immunofluorescence, and immunohistochemistry. It has been extensively tested and validated for use in both in vitro and in vivo experiments, ensuring reliable and reproducible results.
In addition to its use in basic research, this antibody also has potential therapeutic applications. By targeting the L1 protein, it has the potential to prevent HPV16 infection and inhibit the development of cervical cancer.
Some experimental use cases for this antibody include studying the mechanism of HPV16 infection, identifying potential therapeutic targets, and evaluating the efficacy of anti-HPV therapies. Its use in diagnostic assays for HPV16 detection is also being explored.
In summary, the Anti-HPV16 L1/Major capsid protein L1 Antibody (SAA2553) is a valuable tool for researchers studying HPV16 and its implications in cervical cancer. Its high specificity, versatility, and potential therapeutic applications make it a must-have for any biotech laboratory. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22999. For research use only.
Target: L1, Major capsid protein L1; Clonality: Monoclonal Antibody; Applications: Neutralization, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Neutralization |
|---|---|---|---|---|---|---|---|---|---|
| L1, Major capsid protein L1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
